Latest malaria vaccine news
Recent stories and articles on malaria vaccine developments around the world
(Click on headline to read the full story.)
The selection landscape of malaria parasites
May 14, 2010 – Malaria parasites have to survive and transmit within a highly selective and ever-changing host environment. Because immunity to malaria is nonsterilizing and builds up slowly through repeated infections, commonly the parasite invades a host that is immunologically and physiologically different from its previous host.
Science
The selection landscape of malaria parasites
May 14, 2010 – Malaria parasites have to survive and transmit within a highly selective and ever-changing host environment. Because immunity to malaria is nonsterilizing and builds up slowly through repeated infections, commonly the parasite invades a host that is immunologically and physiologically different from its previous host.
Science
Malaria vaccine trials further global health revolution
May 13, 2010 – Global Health 101 at Seattle BioMed tonight was an exciting, easily understood, and meaningful review of the global challenge of malaria and Seattle's part in meeting it. Moderator Gina Rabinovich of The Bill & Melinda Gates Foundation said malaria vaccine trials and our larger fight against malaria are an exemplary front in "the Global Health Revolution."
Open Science Foundation
Seattle BioMed starts malaria trial
May 13, 2010 – Seattle Biomedical Research Institute said today it has officially started the first human clinical trial of its malaria vaccine candidate.
Xconomy
Crucell and NIH announce start of malaria vaccine Trial in Burkina Faso
May 11, 2010 – Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced the start of a Phase I clinical study in Burkina Faso of its AdVac®-based malaria vaccine vector. Crucell is developing its malaria vaccine vector in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) part of the US National Institutes of Health (NIH), the Centre National de Recherche et de Formation sur le Paludisme (CNRFP) in Burkina Faso, and the Noguchi Memorial Institute for Medical Research at the University of Ghana.
Earthtimes.com
MTS49 - Irwin Sherman - The quest for a malaria vaccine: The first hundred years
May 5, 2010 – In this podcast, Carl Zimmer talks with Irwin Sherman, professor emeritus at the University of California at Riverside, about the century-long quest for a vaccine against malaria. Scientists have been trying to make a vaccine for the disease almost since the discovery of the parasite that causes malaria. Yet decade after decade, they've encountered setbacks and failures. We talked about why it's so hard to make a malaria vaccine, and how likely it is that scientists will ever be able to do so in the future.
Meet the Scientist
Goal of eliminating malaria in sight: Experts
Fresh efforts and funding to tackle malaria in recent years have brought the goal of eradicating the deadly disease within sight, health experts said on Friday. Wiping out malaria worldwide could take decades but many countries where it is endemic are on the brink of eliminating the disease, which infects up to 500 million people a year and kills nearly one million worldwide, they said
Reuters
New drugs, vaccine development key to malaria eradication
May 4, 2010 – Developing new medications and vaccines for malaria, as well as establishing treatment and prevention programs in endemic regions will play integral roles in eradicating malaria from the world, according to a panel of speakers at the 2010 Pediatric Academic Societies Annual Meeting, held here.
Pediatric Supersite
Malaria vaccine enters third phase of testing
April 27, 2010 – The third phase of testing for the world's most clinically advanced malaria vaccine candidate began last year and researchers at the Kenya Medical Research Institutes and Centers of Disease Control believe it could lead to the nation's first malaria vaccine by 2015.
Vaccine News Daily
Trials in Africa under way that could make malaria as rare as polio
April 27, 2010 – Every 30 seconds, a child in Africa dies of malaria. The disease is preventable and curable, but there is currently no vaccine for malaria. However, researchers are testing a revolutionary vaccine that could make malaria as rare as polio, a disease that has nearly been eradicated. The drug tests were happening as the international community marked World Malaria Day on Sunday and pledged more funds to fight the disease.
The National
Malaria vaccine research makes headway
April 26, 2010 – "Despite low technology, Tanzanian scientists have gone a long way in research on a malaria vaccine," said Dr Gilbert Mliga, the director of human resources, at the Ministry of Health and Social Welfare at The Tanzania Malaria Control Forum 2010 held on Thursday in Dar es Salaam. Dr Mliga praised the National Institute for Medical Research for creating an environment which has enabled local institutes to conduct research on malaria easily.
Kenya Broadcasting Corporation
Malaria vaccine trials for Kenya
April 25, 2010 – Scientists involved in the trial of a vaccine against malaria say they are optimistic they can defeat the disease. Early tests of the vaccine showed it could provide complete protection for some people.
Al Jazeera
Help to kick out malaria by 2017
April 24 2010 – Kenya joins the global community in commemorating World Malaria Day on Sunday at a very optimistic moment with evidence that the disease can actually be brought under control or even eliminated. The country aims to kick malaria out of Kenya in seven years in an expensive campaign that could cost more than $100 million annually.
Daily Nation
Sugar preserves vaccines without refrigeration
February 17, 2010 – British researchers have developed a new way of preserving vaccines without refrigeration by sealing the vaccine's live viruses inside glass made of sugar.
CBC
Africa: Melinda Gates lauds health and economic advances for continent's poorest
February 12, 2010 – Despite impressive economic growth across Africa in recent years, the distribution of wealth has been uneven, and pernicious poverty persists.
allAfrica.com
Malaria parasite genome studied
February 9, 2010 – Scientists at Singapore's Nanyang Technological University say they have completed the world's first in-depth study of the malaria parasite genome.
UPI
Ally for the poor in an unlikely corner
February 8, 2010 –
Andrew Witty is not quite as young or as buff as Anderson Cooper, but he does do interviews in shirtsleeves from the slums of Nairobi and rural hospitals in Uganda.
New York Times
The man who keeps the GSK ball rolling
February 6, 2010 –
Andrew Witty knows he can't please all of the people all of the time... Investors probably won't be too impressed by the comparatively paltry profit margins should the company's efforts to produce the world's first child vaccine against malaria come to fruition in what would be a landmark in 21st century progress.
Daily Telegraph (UK)
New malaria vaccine shows promise in children
February 3, 2010 –
A new vaccine showed promise at protecting young children from malaria, offering a potential new weapon against a disease that kills at least 1 million people each year.
Reuters
Bill Gates tells The Times about his $10bn plan to save 8 million children
January 30, 2010 –
For most people, a 329-page compendium of World Bank data on development and disease in the early 1990s would be, at best, an arid read. But most people don't see the world quite like bill Gates.
The Times London
Bill Gates promises $10 billion for vaccines
January 29, 2010 –
Bill and Melinda Gates said on Friday they would spend $10 billion over the next decade to develop and deliver vaccines, an increased commitment that reflects progress in the pipeline of products for immunizing children in the developing world.
Reuters
Gates to pump $10 billion into vaccines
January 29, 2010 –
Philanthropists Bill Gates and Melinda Gates said Friday they would spend $10 billion to develop and deliver new vaccines over the next decade, highlighting growing concerns that the global recession and competing government priorities will stifle efforts to control diseases in developing countries.
Wall Street Journal
Gates says malaria vaccine may be ready in three years
January 26, 2010 –
Microsoft founder Bill Gates has told the BBC that a vaccine for malaria could be just three years away.
BBC
2010 annual letter from Bill Gates
January 25, 2010 – Two years ago, Bill & Melinda Gates challenged the health field to set a goal of eventually eradicating malaria. It is such a widespread disease, the foundation has backed a number of different types of innovations.
Saving the world, 2.0
January 25, 2010 –
How do you address global hunger, epidemics, and poverty? According to Bill Gates, it takes R&D, software, and plenty of money.
Newsweek
GlaxoSmithKline to make 'affordable' malaria drugs
January 20, 2010
–
The world's second biggest pharmaceutical company GlaxoSmithKline (GSK) has unveiled a series of initiatives which it says will improve access to medicines in developing nations.
BBC
GSK offers to share data to help fight malaria fight
January 20, 2010 –
Andrew Witty, chief executive of GSK and the driving force behind the move, said the drug company has a "genuine appetite to change the landscape of healthcare for the world's poorest people".
Daily Telegraph (UK)
GSK offers scientists labs, data to fight malaria
January 20, 2010 –
Drugmaker GlaxoSmithKline said Wednesday it will open up its research cupboards and labs to outside scientists in an unusual effort to trigger more research on malaria and other neglected tropical diseases.
Associated Press
Glaxo eyes token profit on malaria vaccine
January 20, 2010 –
GlaxoSmithKline Plc (GSK.L) hopes to seek approval by 2012 for its experimental vaccine to prevent malaria and will seek only a small profit on the product in order to make it widely available in hard-hit countries, the company said.
Reuters
